Executive Series: James Gianoutsos (Rimsys) - AI, Market Access, and the Future of Regulatory Work

Host Steve Gens sits down with James Gianoutsos, founder and CEO of Rimsys, for a wide-ranging discussion on how AI is reshaping regulatory work in medtech. They explore emerging market-access models, the shift toward AI-supported impact assessments, evolving validation expectations, and how regulatory teams are adapting to a rapidly changing digital landscape. If you'd like to learn more about Rimsys, check out their website: https://www.rimsys.io/